A. The plaintiff A is a person who received the following medical treatment at the Gancheon Hospital of the Gyeonggi-do Medical Center operated by the defendant (hereinafter "the defendant hospital"), and the plaintiff B is the spouse of the plaintiff A, and the plaintiff C and D are the children of the plaintiff A.

B. On February 7, 2011 and February 15, 2014, Plaintiff A showed a telegraphic algorier reaction after taking a pharmathic drug.

From February 17, 2014, the above Plaintiff knew that there was a side effect on the remaining drugs to medical doctors E, while receiving alone’s treatment from the Defendant Hospital, and that there was a side effect on the remaining drugs, which is a residual ingredient, on the records of patient treatment against the above Plaintiff.

C. On March 13, 2014, Plaintiff A visited Defendant Hospital on the ground that it was marry.

E prescribed for the Plaintiff A in Catus Manikis (including Latherzins) ingredients.

Plaintiff

A, after the injection, he was unable to be able to appeal for scarcitys (or heatis cream) and caused low-carbon cerebral brain damage.

(hereinafter “instant accident”). D.

Plaintiff

A currently shows physical disability, recognition disorder, and language disorder, such as telegraph paralysis, spathy disorder, and spathy disorder as a so-called "satisfy plant condition", and as a result of the examination of brain-satisfymal satisfy, it is anticipated that a permanent post-m

E. Meanwhile, prior to the instant accident, A did not have any particular symptoms or signs likely to cause low carbon brain damage.

[Grounds for Recognition: Facts without dispute, entry of Gap evidence 1 and 2, results of physical evaluation commissioned to the president of the Central University Hospital of this Court, results of fact inquiry to the chief of the National Health Insurance Corporation of this Court, the purport of the whole pleadings

2. According to the above fact of recognition of the liability for damages, E has the duty of care to avoid and prescribe the affiliated drugs, because it was aware that the Plaintiff may cause side effects, such as shocks, when prescribing the drugs containing Latlidine ingredients.